Blog
Privacy Assurance FAQ
What is Privacy Assurance? One of the benefits of synthetic data is that it has low ...
Blog
Synthetic Data Generation FAQ
What is synthetic data generation (SDG)? There are many ways to generate synthetic data. ...
Blog
Aetion® Generate FAQ
What is Generate? Aetion® Generate, formerly Replica Synthesis, is Aetion’s scalable ...
Blog
Research spotlight: RWD transferability across borders
Manufacturers are increasingly using real-world data (RWD) to generate real-world ...
Blog
A Solution for Payers to Use Real World Evidence in Pharma Confidently
Tackling three common concerns
Blog
RWE Meaning | Update: What the Omnibus FDA Amendments Mean for RWE
On December 29, 2022, President Biden signed the Consolidated Appropriations Act, 2023, a ...
Blog
Replica Analytics Top 10 Round-up for 2022
By Replica staff
Blog
Validating a Membership Disclosure Metric for Synthetic Health Data
By Lucy Mosquera | Posted On: October 11, 2022 We have just had a paper published in ...
Blog
RWE guidance watch: EUnetHTA’s Direct and Indirect Comparisons guidance
The European Network for Health Technology Assessment (EUnetHTA) recently published two ...
Blog
Aetion’s best practices referenced in ENCePP’s updated Guide on Methodological Standards in Pharmacoepidemiology
On July 1, 2022, the European Network of Centres for Pharmacoepidemiology and ...
Blog
New estimator uses synthetic data generation for more reliable evaluation of re-identification risk in datasets
By Lucy Mosquera and Abhik Das
Blog
Why work at a startup? Because everything you do matters
Several years ago, during a hiring interview for a software engineer position, the ...
Blog
ISPOR Goes Real-World
Regulators, HTAs, and pharma leaders discuss RWE trends with Aetion experts.
Blog
RWE Guidance: NICE’s RWE Framework
This month, the UK’s National Institute for Health and Care Excellence (NICE) released ...
Blog
Utility Metrics for Evaluating Synthetic Data Generation Methods
By Lucy Mosquera and Xi Fang Posted On: April 8, 2022 In order to work with synthetic ...
Blog
Blog post from CHEO Research Institute
By Replica Analytics staff Posted On: March 24th, 2022 This week, the CHEO Research ...
Blog
Synthetic Data Generation for Implementing the HIPAA Expert Determination Method
By Khaled El Emam Posted On: March 1st, 2022 The Expert Determination method is one of ...
Blog
Re-identification–the wrong criterion for synthetic data
By Khaled El Emam Posted On: February 17th, 2022
Blog
Aetion’s comments to FDA on data standards for RWD in drug and biological product submissions
Last week, Aetion submitted a letter to FDA commenting on the Agency’s recent draft ...
Blog
Speaking with Canadian legislators about anonymization
By Replica staff Posted On: February 9th, 2022
Blog
Aetion’s comments to FDA on electronic health records and claims to support regulatory decisions
Last week, Aetion submitted a letter to FDA commenting on the Agency’s recent draft ...
Blog
Understanding propensity score weighting methods
Oftentimes researchers want to compare two medications—an existing medication to a newly ...
Blog
PETs protect privacy and enable data use and sharing for good
By Khaled El Emam Posted On: January 28th, 2022
Blog
Hot off the presses: Replica’s acquisition by Aetion generates coverage
By Replica Analytics staff Posted On: January 24th, 2022